Non-Traditional Risk Factors in Clinical Trials

When serious things go wrong with a trial, such as an adverse event or an incident report is filed, it is easier for project managers to identify a problem that needs to be addressed in a trial. However, it is the unanticipated and less obvious situations that happen throughout the trial that can put it at risk.

Mark Hronec, Director of PriceWaterhouseCoopers, noted during a December 2013 webinar sponsored by SAS and Applied Clinical Trials titled Myths, Models and Momentum: Risk-Based Monitoring this exact situation. He termed them traditional and non-traditional risk factors. Along the traditional were those previously mentioned—recruitment rates, protocol deviations, serious adverse events, the drug safety profile or the site location or experience at the site. However, those non-traditional risks that could be identified and leveraged using real-time “big data” predictors included average patient visit window deviation, the number of visits the site has per day, the number of inclusion or exclusion criteria, the length of the informed consent form, among others.